Document
IPR2021-00406, No. 1005-5 Exhibit - Curriculum Vitae of Dr Igor Gonda (P.T.A.B. Jan. 7, 2021)
Cite Document
IPR2021-00406, No. 1005-5 Exhibit - Curriculum Vitae of Dr Igor Gonda (P.T.A.B. Jan. 7, 2021)
+ More Snippets
Document
IPR2021-00406, No. 1130-222 Exhibit - January 27, 2020 Press Release ���Liquidia Submits New Drug Application for LIQ861 treprostinil inhalation powder to US Food and Drug Administration fo...
Cite Document
IPR2021-00406, No. 1130-222 Exhibit - January 27, 2020 Press Release ���Liquidia Submits New Drug Application for LIQ861 treprostinil inhalation powder to US Food and Drug Administration for the Treat
+ More Snippets
Document
IPR2021-00406, No. 2019-97 Exhibit - EX2019 UT v Liquidia, D Del, ECF 49 (P.T.A.B. May. 17, 2021)
Cite Document
IPR2021-00406, No. 2019-97 Exhibit - EX2019 UT v Liquidia, D Del, ECF 49 (P.T.A.B. May. 17, 2021)
+ More Snippets
Document
IPR2021-00406, No. 1016-16 Exhibit - 10,376,525 Patent Prosecution History excerpted (P.T.A.B. Jan. 7, 2021)
Cite Document
IPR2021-00406, No. 1016-16 Exhibit - 10,376,525 Patent Prosecution History excerpted (P.T.A.B. Jan. 7, 2021)
+ More Snippets
Document
IPR2021-00406, No. 2095-225 Exhibit - Ex 2095 Butler Deposition (P.T.A.B. Mar. 16, 2022)
Cite Document
IPR2021-00406, No. 2095-225 Exhibit - Ex 2095 Butler Deposition (P.T.A.B. Mar. 16, 2022)
+ More Snippets
Document
IPR2021-00406, No. 2036-165 Exhibit - Ex 2036 McLaughlin 2003 (P.T.A.B. Nov. 10, 2021)
Cite Document
IPR2021-00406, No. 2036-165 Exhibit - Ex 2036 McLaughlin 2003 (P.T.A.B. Nov. 10, 2021)
+ More Snippets
Document
IPR2021-00406, No. 1118-210 Exhibit - PubMedgov search results for Sulica, R and Poon, M, ���Medical therapeutics for pulmonary arterial hypertension from basic science and clinical trial desi...
Cite Document
IPR2021-00406, No. 1118-210 Exhibit - PubMedgov search results for Sulica, R and Poon, M, ���Medical therapeutics for pulmonary arterial hypertension from basic science and clinical trial design to ev
+ More Snippets
Document
IPR2021-00406, No. 2083-156 Exhibit - Ex 2083 Treprostonil Pub Chem (P.T.A.B. Nov. 10, 2021)
Cite Document
IPR2021-00406, No. 2083-156 Exhibit - Ex 2083 Treprostonil Pub Chem (P.T.A.B. Nov. 10, 2021)
+ More Snippets
Document
IPR2021-00406, No. 2087-161 Exhibit - Ex 2087 Sandifer 2005 (P.T.A.B. Nov. 10, 2021)
Cite Document
IPR2021-00406, No. 2087-161 Exhibit - Ex 2087 Sandifer 2005 (P.T.A.B. Nov. 10, 2021)
+ More Snippets
Document
IPR2021-00406, No. 2035-113 Exhibit - EX2035 Bourge, 2013, Cardiovascular Therapeutics (P.T.A.B. May. 17, 2021)
Cite Document
IPR2021-00406, No. 2035-113 Exhibit - EX2035 Bourge, 2013, Cardiovascular Therapeutics (P.T.A.B. May. 17, 2021)
+ More Snippets
Document
IPR2021-00406, No. 2004-82 Exhibit - EX2004 Declaration of Dr Hossein A Ghofrani (P.T.A.B. May. 17, 2021)
Cite Document
IPR2021-00406, No. 2004-82 Exhibit - EX2004 Declaration of Dr Hossein A Ghofrani (P.T.A.B. May. 17, 2021)
+ More Snippets
Document
IPR2021-00406, No. 1058-56 Exhibit - Ziegler, J and Wachtel, H, ¿¿¿Comparison of Cascade Impaction and Laser Diffraction for Particle Size Distribution Measurements,¿¿¿ Journal of Aerosol Med...
Cite Document
IPR2021-00406, No. 1058-56 Exhibit - Ziegler, J and Wachtel, H, ¿¿¿Comparison of Cascade Impaction and Laser Diffraction for Particle Size Distribution Measurements,¿¿¿ Journal of Aerosol Medicine, 18
+ More Snippets
Document
IPR2021-00406, No. 1064-61 Exhibit - Dolovich, MB, et al, ¿¿¿Device Selection and Outcomes of Aerosol Therapy Evidence Based Guidelines,¿¿¿ CHEST, 127335 71 2005 (P.T.A.B. Jan. 7, 2021)
Cite Document
IPR2021-00406, No. 1064-61 Exhibit - Dolovich, MB, et al, ¿¿¿Device Selection and Outcomes of Aerosol Therapy Evidence Based Guidelines,¿¿¿ CHEST, 127335 71 2005 (P.T.A.B. Jan. 7, 2021)
+ More Snippets
Document
IPR2021-00406, No. 1075-71 Exhibit - November 17, 2008 Press Release, ¿¿¿Eli Lilly and Company Licenses US Rights for Tadalafil PAH Indication to United Therapeutics Corporation (P.T.A.B. J...
Cite Document
IPR2021-00406, No. 1075-71 Exhibit - November 17, 2008 Press Release, ¿¿¿Eli Lilly and Company Licenses US Rights for Tadalafil PAH Indication to United Therapeutics Corporation (P.T.A.B. Jan. 7, 2021
+ More Snippets
Document
IPR2021-00406, No. 1121-213 Exhibit - Ghofrani 2005, British Library (P.T.A.B. Feb. 10, 2022)
Cite Document
IPR2021-00406, No. 1121-213 Exhibit - Ghofrani 2005, British Library (P.T.A.B. Feb. 10, 2022)
+ More Snippets